- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$18.43 BnMarket Estimate, 2026
$19.94 BnMarket Forecast, 2034
$37.46 BnCAGR, 2026–2034
8.2%Global Cholesterol Testing Services Market Size, Growth, Trends & Forecast (2026–2034)
The global cholesterol testing services market size was valued at USD 18.43 billion in 2025, is estimated at USD 19.94 billion in 2026, and is expected to reach USD 37.46 billion by 2034, registering a compound annual growth rate (CAGR) of 8.2% from 2026 to 2034. Driven by the escalating prevalence of cardiovascular diseases, rising obesity rates, an expanding aging demographic, and an increased global emphasis on preventive healthcare screening, the market maintains steady momentum worldwide.
Key Executive Metrics (At-a-Glance)
- 2025 Base Valuation: USD 18.43 Billion
- 2026 Current Valuation: USD 19.94 Billion
- 2034 Forecast Valuation: USD 37.46 Billion
- Compound Annual Growth Rate (CAGR): 8.2% (2026–2034)
- Dominant Customer Segment: Physicians, Providers, and Hospitals (clinical reliability, structured reimbursement frameworks, and risk assessments)
- Fastest-Growing Customer Segment: Patients / Direct-to-Consumer & Government Agencies (preventive care focus and easy access to lab networks)
- Dominant Region: North America (established healthcare infrastructure and high screening volumes)
- Fastest-Growing Region: Asia-Pacific (large population base, rising cardiovascular disease incidence, and expanding testing facilities)
Core Market Drivers
- Cardiovascular Disease & Obesity Burden: High rates of heart disease, strokes, and sedentary lifestyles driving routine lipid panels and early diagnostic testing.
- Preference for Laboratory Testing: High clinical confidence in professional laboratory assessments (total cholesterol, HDL, LDL, and triglycerides) over home self-testing kits.
Primary Market Restraints & Challenges
- Alternative Self-Testing Options: Proliferation of over-the-counter home cholesterol monitoring kits and non-invasive testing techniques posing competition for routine lab services.
Global Cholesterol Testing Services Market Segmentation Breakdown
| Segment Category | Leading Sub-Segment (Base Year) | Fastest-Growing Sub-Segment |
|---|---|---|
| By Type of Customer | Physicians, Providers, & Hospitals | Patients & Government/Public Health Agencies |
| By Region | North America (Market leader) | Asia-Pacific (Highest CAGR expansion) |
Major Industry Players Profiled
Key enterprises shaping the competitive global cholesterol testing service market include Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific, Spectra Laboratories Inc., Unilabs, SYNLAB International GmbH, Bio-Reference Laboratories Inc., Clinical Reference Laboratory, Inc. (CRL), ACM Medical Laboratory, and Adicon Clinical Laboratory.
Global Cholesterol Testing Service Market Size
The size of the global cholesterol testing services market was worth USD 18.43 billion in 2025. The global market is anticipated to grow at a CAGR of 8.2% from 2026 to 2034 and be worth USD 37.46 billion by 2034 from USD 19.94 billion in 2026.
Cholesterol is a waxy, fat-like substance found in every cell of our body. If you have too much cholesterol in your blood, it can combine with other elements in your blood to form plaque that sticks to the walls of the arteries. A complete cholesterol test is also referred to as a lipid panel or lipid profile. Your doctor will measure the amount of "good" and "bad" cholesterol and triglycerides, a type of fat in the blood. High cholesterol levels lead to health hazards such as the acute risk of stroke and heart disease and cause many deaths. Cholesterol screening services enable the early detection of high-cholesterol-related problems to avoid complications and increase patient survival.
MARKET DRIVERS
The growing incidence of cardiovascular disease, rising adoption of a sedentary lifestyle, an increase in the geriatric population, and government initiatives to improve healthcare delivery are majorly propelling the growth of the global cholesterol testing services market.
The global cholesterol testing services market is further driven by doctors' preference for laboratory testing over self-testing and the rise in healthcare spending. A significant risk of stroke and heart disease, both of which cause a substantial number of deaths, are increased by high cholesterol levels. The expansion of the cholesterol testing services market is fuelled by discovering issues early to avoid complications, gradual awareness of the dangers of cholesterol and education about the importance of these tests, technological advancements in cholesterol laboratory testing services, and enhancing the patient's chances of life. Because high cholesterol has no symptoms, comprehensive cholesterol testing is required. Total cholesterol, high-Density Lipoprotein (HDL), low-Density Lipoprotein (LDL), and triglycerides are the four lipids measured in the blood. Measurements of blood cholesterol helps to reduce the risk of heart attack, stroke, and peripheral artery disease.
Another disease associated with high cholesterol is obesity. The need for these tests will grow as the incidence of cholesterol-related illnesses rises, boosting the global laboratory cholesterol testing market. Cholesterol lab testing services provide for early diagnosis of issues, avoiding complications, and improving patients' chances of life. The market for cholesterol lab testing services is projected to expand as a result of this. Because of their increased focus on preventive care and early detection to avert major illness problems, the government agencies segment is anticipated to develop significantly in the coming years. The major companies in the market collaborate with federal, state, and local government organizations to deliver high-quality diagnostic testing services worldwide. According to the Centers for Disease Control and Prevention (CDC), adults aged 40 to 59 have the highest total cholesterol. This is mostly due to a sedentary lifestyle, which has been linked to the development of several diseases, including obesity, diabetes, and heart disease. As a result, it is expected that there would be a greater awareness of the importance of routine cholesterol testing and treatment.
MARKET RESTRAINTS
In addition to the restrictions presented by the development of non-invasive cholesterol testing techniques, the existence of home or self-test kits might limit expansion. Therefore, leading companies are concentrating on developing new and sophisticated monitoring devices to overcome the challenges of existing equipment, resulting in intense competition in the worldwide cholesterol testing services market.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| Segments Covered | By Type of Customer and Region. |
| Various Analyses Covered | Global, Regional, and Country-Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Market Leaders Profiled | Laboratory Corporation of America Holdings (Lab Corp.) (USA), Quest Diagnostics Incorporated (USA), Eurofins Scientific (Luxembourg) and Spectra Laboratories Inc. (USA), Unilabs (Switzerland), SYNLAB International GmbH (Germany), Bio-Reference Laboratories Inc. (USA), Clinical Reference Laboratory, Inc. (CRL) (USA), ACM Medical Laboratory (USA), dicon Clinical Laboratory (China)., and Others. |
SEGMENTAL ANALYSIS
By Type of Customer Insights
The physicians, providers, and hospital segments are estimated to account for most of the market share during the forecast period. Factors such as growing reimbursement scenarios, physicians' assurance on cholesterol test outcomes making the cardiovascular disease risk assessments, and treatment-based decisions are forecasted to accelerate the growth of these segments.Besides the above, the patient segment is expected to be another lucrative segment and is predicted to register a healthy growth rate during the forecast period. The easy availability of diagnostic lab centers for test services and rising healthcare awareness are expected to boost this segment. Moreover, factors such as access to lab test reports, easy accessibility of lab tests without physician intervention, increased government measures in developing the testing quality, the rising aging population, and the obese population support market growth.
REGIONAL ANALYSIS
Geographically, North America is expected to dominate the market for cholesterol testing in 2024, and the United States is an essential part of it. However, Asia is expected to be the fastest-growing region in CAGR over the forecast period due to the large population base, the increase in cardiovascular disease, and the increasing number of test facilities in Asia.
KEY MARKET PLAYERS
Notable companies leading the global cholesterol testing service market profiled in this report are
- Laboratory Corporation of America Holdings (LabCorp)
- Quest Diagnostics Incorporated
- Eurofins Scientific
- Spectra Laboratories Inc.
- Unilabs
- SYNLAB International GmbH
- Bio-Reference Laboratories Inc.
- Clinical Reference Laboratory, Inc. (CRL)
- ACM Medical Laboratory
- Adicon Clinical Laboratory
MARKET SEGMENTATION
This research report on the global cholesterol testing service market has been segmented and sub-segmented based on the type of customer and region.
By Type of Customer
- Physician
- Provider
- Hospital
- Employer
- Health Plan
- MCO
- Government
- ACO
- IDN
- Patient
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- The Middle East and Africa